seventeen consecutive , well stratified stage ii and iii myeloma patients were given differentiated , combination chemotherapy ( cyclophosphamide , vincristine , daunorubicin , etoposide , teniposide , lomustine ( ccnu ) , procarbazine , cytosine arabinoside , and prednisolone ) , which was more intensive in advanced stages and changed as soon as the patients became refractory .
C0026764
myeloma
C0033223
procarbazine